Detalhe da pesquisa
1.
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.
Mult Scler
; 28(13): 2137-2141, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296189
2.
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening.
Mult Scler
; 28(3): 472-479, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132146
3.
In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology.
Brain
; 144(1): 186-197, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221873
4.
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study.
Neurol Sci
; 43(11): 6415-6423, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781765
5.
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
N Engl J Med
; 379(11): 1017-1027, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207920
6.
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges.
Mult Scler
; 27(3): 479-482, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32539596
7.
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.
Mult Scler
; 27(12): 1814-1822, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552353
8.
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study.
Mult Scler
; 27(6): 922-932, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32633694
9.
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
Brain
; 143(10): 3013-3024, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935843
10.
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.
J Neurol Neurosurg Psychiatry
; 91(5): 483-492, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132224
11.
Correction to: Aging with multiple sclerosis: prevalence and profile of cognitive impairment.
Neurol Sci
; 41(1): 243, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31713757
12.
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.
Mult Scler
; 25(3): 399-407, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363396
13.
Correction to: Cognitive assessment in multiple sclerosis-an Italian consensus.
Neurol Sci
; 40(5): 1097, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30900096
14.
Correction to: The Italian multiple sclerosis register.
Neurol Sci
; 40(4): 907, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30815752
15.
The Italian multiple sclerosis register.
Neurol Sci
; 40(1): 155-165, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426289
16.
Aging with multiple sclerosis: prevalence and profile of cognitive impairment.
Neurol Sci
; 40(8): 1651-1657, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31011932
17.
Prognostic indicators in pediatric clinically isolated syndrome.
Ann Neurol
; 81(5): 729-739, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439957
18.
The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis (editorial on: Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial).
Mult Scler
; 29(6): 668-670, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960483
19.
Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study.
Mult Scler
; 24(2): 167-174, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273776
20.
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study.
Mult Scler
; 24(9): 1234-1242, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654357